ENSC
Ensysce Reports Q3 2026 Results and Buys Cy Biopharma
The company reported strengthened cash reserves and announced the acquisition of Cy Biopharma to support its CRPS drug pipeline.
Latest 1 stories · newest Nov 12, 2026
The company reported strengthened cash reserves and announced the acquisition of Cy Biopharma to support its CRPS drug pipeline.
The same ENSC feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/ENSC/newsSTART FREE